Wednesday, August 31, 2022

USFDA issues Form 483 with one observation to Aurobindo Pharma subsidiary's plant

USFDA issues Form 483 with one observation to Aurobindo Pharma subsidiary's plant

Aurobindo Pharma 


https://thehealthmaster.com/?p=40827

No comments:

Post a Comment